Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewLonafarnib is a potent farnesyl transferase inhibitor (IC50 = 1.9 nM). Inhibits farnesylation of RAS. Also inhibits Pgp transport (IC50 < 3 μM) and increases potency and anticancer activity when used in conjunction with cytotoxic Pgp substrates. Inhibits neovascularization by affecting cell motility. Orally bioavailable.
分子量 | 638.82 |
公式 | C27H31Br2ClN4O2 |
储存 | Store at -20°C |
纯度 | ≥98% (HPLC) |
CAS Number | 193275-84-2 |
PubChem ID | 148195 |
InChI Key | DHMTURDWPRKSOA-RUZDIDTESA-N |
Smiles | NC(N1CCC(CC1)CC(N2CCC([C@H]3C4=NC=C(C=C4CCC5=CC(Cl)=CC(Br)=C35)Br)CC2)=O)=O |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
溶剂 | 最高浓度 mg/mL | 最高浓度 mM | |
---|---|---|---|
溶解性 | |||
DMSO | 6.39 | 10 |
以下数据基于产品分子量 638.82。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
浓度/溶剂体积/质量 | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 15.65 mL | 78.27 mL | 156.54 mL |
0.5 mM | 3.13 mL | 15.65 mL | 31.31 mL |
1 mM | 1.57 mL | 7.83 mL | 15.65 mL |
5 mM | 0.31 mL | 1.57 mL | 3.13 mL |
参考文献是支持产品生物活性的出版物。
Bowman et al (2015) Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer. Sci.Signal. 8 PMID: 25628462
Lo Cicero et al (2016) A high throughput phenotypic screening reveals compounds that counteract premature osteogenic differentiation of HGPS iPS-derived mesenchymal stem cells. Sci.Rep. 6 34798 PMID: 27739443
Sun et al (2015) Lonafarnib is a potential inhibitor for neovascularization. PLoS One. 10 e0122830 PMID: 25853815
Wang et al (2001) The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein. Cancer.Res. 61 7525 PMID: 11606389
Nielsen et al (1999) Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models. Cancer Res. 59 5896 PMID: 10606231
Shen et al (2015) Farnesyltransferase and geranylgeranyltransferase I: structures, mechanism, inhibitors and molecular modeling. Drug Discov.Today. 20 267 PMID: 25450772
If you know of a relevant reference for Lonafarnib, please let us know.
关键词: Lonafarnib, Lonafarnib supplier, Lonafarnib, SCH66336, farnesyl, transferase, inhibitors, inhibits, PgP, transport, anticancer, neovascularization, orally, bioavailable, Protein, Prenyltransferases, Post-translational, Modifications, 6265, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。 Lonafarnib 的部分引用包括:
Daniel E et al (2022) Progerin-expressing endothelial cells are unable to adapt to shear stress. Biophys J 121 620-628 PMID: 34999130
您是否知道使用了 Tocris Lonafarnib 的优秀论文? 请告知我们.
目前没有该产品的评论。 Be the first to review Lonafarnib and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image